Lung Function After Robot-assisted Radical Prostate Ectomy
NCT ID: NCT02066246
Last Updated: 2014-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
192 participants
INTERVENTIONAL
2013-08-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As a second purpose of the study, in a subgroup, we investigate the influence of the gas insufflators (AirSeal and conventional) on hemodynamics during surgery. Furthermore we study the change in the lung perfusion-ventilation-ratio by using the electric impedance tomography technique.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Using the Airseal System with Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: a Prospective, Comparative, Randomized Clinical Study.
NCT06784986
Ultralow Versus Standard Pneumoperitoneum Pressure
NCT03630393
Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies
NCT02114164
Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT06540794
Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy
NCT07262073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Olympus UHI-3
patients are treated with the Olympus UHI-3-CO2-insufflation and trocar system
Olympus UHI-3
100 patients are treated with a conventional insufflation and trocar system
AirSeal
patients are treated with the AirSeal-CO2-insufflator and trocar-system
AirSeal
100 patients are treated with the AirSeal insufflation and trocar system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AirSeal
100 patients are treated with the AirSeal insufflation and trocar system
Olympus UHI-3
100 patients are treated with a conventional insufflation and trocar system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* ≥ 18 years of age
Exclusion Criteria
* Patients who refuse participating in the study
* Obstructive airway disease (COPD and Asthma)
* Postoperative admission to an intensive or intermediate care unit
* Patients who do not speak German or English
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prostate Center North West Department of Urology and Pediatric Urology
UNKNOWN
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel A Reuter, PhD MD
Role: STUDY_DIRECTOR
Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg
Alexander März, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg
Günter Lippert, MD
Role: PRINCIPAL_INVESTIGATOR
Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany .
Alexander Haese, PhD MD
Role: PRINCIPAL_INVESTIGATOR
Martini Clinic, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Jörn Witt, MD
Role: PRINCIPAL_INVESTIGATOR
Prostate Cancer Center North West, at St. Antonius-Hospital, Gronau, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prostate Cancer Center Northwest, at St. Antonius Hospital Gronau
Gronau, , Germany
Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANA-UKE-PV4374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.